• Product
• This situation of mixing Lyrica with other doses is absurd
• by Kang, Shin-Kook Mar 22, 2021 06:16am

• Company
• Keytruda is expected to expand its indications
• by Eo, Yun-Ho Mar 19, 2021 06:29am

• Opinion
• [Reporter’s Eye] For unbiased KPBMA ethics committee
• by Mar 19, 2021 06:28am

• Policy
• AZ vaccine plan can be updated after reviewing EMA's results
• by Lee, Jeong-Hwan Mar 19, 2021 06:28am

• Policy
• AZ and Pfizer COVID-19 vaccines to arrive on Mar. 24
• by Kim, Jung-Ju Mar 19, 2021 06:27am

• Policy
• Pfizer vaccine is recommended for seniors 65 and older
• by Lee, Jeong-Hwan Mar 19, 2021 06:27am

• Policy
• Sovaldi's criteria for re-examination are relaxed
• by Lee, Tak-Sun Mar 18, 2021 08:26am

• Company
• The outpatient Rx market is shrinking in this winter
• by Chon, Seung-Hyun Mar 18, 2021 06:22am

• Company
• Industry to yet again drive for flexible use of ICER
• by Eo, Yun-Ho Mar 18, 2021 06:20am

• Company
• Chinese regulator cracks down on illegal Botox distribution
• by Nho, Byung Chul Mar 18, 2021 06:19am